American Vietnamese Biotech Incorporation reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was VND 52,934.51 million compared to VND 96,048.91 million a year ago. Net income was VND 4,870.74 million compared to VND 6,040.78 million a year ago. Basic earnings per share from continuing operations was VND 37 compared to VND 45 a year ago.
For the nine months, revenue was VND 150,745.17 million compared to VND 222,866.26 million a year ago. Net income was VND 10,100.16 million compared to VND 52,168.89 million a year ago. Basic earnings per share from continuing operations was VND 77 compared to VND 525 a year ago.